AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2017

Jan 19, 2017

34129_dirs_2017-01-19_d41e0b2a-dd6d-4f7b-b102-f602f3d4365f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2016-12-31

Reporting Person: Koenig Scott (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-17	Common Stock	J	79898	—	Disposed	53265	Direct
2016-05-18	Common Stock	J	34619	—	Disposed	53265	Direct
2016-05-17	Common Stock	J	79898	—	Acquired	167782	Indirect
2016-05-18	Common Stock	J	34619	—	Acquired	167782	Indirect

Footnotes

F1: (1) Transaction was a transfer of direct ownership by reporting person to indirect ownership (Family Trust). Closing price on 5/17/16 was $18.04 per share.

F2: (2) Transaction was a transfer of direct ownership by reporting person to indirect ownership (Family Trust). Closing price on 5/18/16 was $21.06 per share.